Study of the pharmacokinetics of suprastin and fencarol in rats by the method of highly effective liquid cheromatography

Purpose Inhibition of focal adhesion kinase-vascular endothelial growth factor receptor 3 complex by C4 was previously shown to reduce tumor growth alone and synergistically with other chemotherapeutic agents in animal tumor models. Single and multiple dose IV and oral dosing studies were performed in dogs to determine C4 pharmacokinetics. Methods C4 was administered to 4 dogs at 1.25 or 2.50 mg/kg IV, or 7.50 mg/kg oral gavage. Single-(IV and oral) and multiple- (IV) dose pharmacokinetic samples were collected on days 1 and 3 at predose and 0.5, 1, 2, 4, 8, 24, 120, 144, and 168 hrs post-dose. C4 concentrations were determined using liquid chromatography with tandem mass spectral detection with a limit of quantitation of 2.50 pg/mL. Pharmacokinetics of C4 was characterized by a 3-compartment model with linear distributional and elimination clearances using Phoenix 64 WinNonlin 6.3. Results Mean C4 plasma concentration-time profiles revealed a triexponential decline following either IV or oral administration, independent of dose with no accumulation. For the 2.5 mg/kg dose, the median half-life was approximately 21 hrs. Median Cmax and area-under-the-curve (AUC0-24) was similar for Days 1 and 3. Oral bioavailability for formulations of PBS, TPGS, Maalox®, and Pepcid® was greatest with TPGS (45%), followed by Maalox® (42%), Pepcid® (37%), and PBS (30%) Conclusions The pharmacokinetic study revealed C4 has linear pharmacokinetics and does not accumulate following multiple dose administration. Characterization of C4 pharmacokinetics provides a better understanding of the novel targeted agent, which will help facilitate further development of C4.

show abstract

Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs

Wilton

Kurenova

Pitzonka

et al. 2014

Eur J Drug Metab Pharmacokinet

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Study of the pharmacokinetics of suprastin and fencarol in rats by the method of highly effective liquid cheromatography

Cited by 1 publication

References 1 publication

Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs

Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs

Contact Info

Product

Resources

About